Search Results - "Wang, Zhouchong"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization by Shen, Yinan, Wei, Yongpeng, Wang, Zhouchong, Jing, Yingying, He, Haiguan, Yuan, Jianyong, Li, Rong, Zhao, Qiudong, Wei, Lixin, Yang, Tian, Lu, Junhua

    Published in Cellular physiology and biochemistry (01-01-2015)
    “…Background/Aims: TGF-β plays a key role in the progression of various tumors. The main objective of our study was to investigate whether TGF-β is able to…”
    Get full text
    Journal Article
  2. 2

    Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma by Xing, Hao, Yan, Cunling, Cheng, Liming, Wang, Nianyue, Dai, Shuyang, Yuan, Jianyong, Lu, Wenfeng, Wang, Zhouchong, Han, Jun, Zheng, Yijie, Yang, Tian

    Published in Tumor Biology (01-12-2016)
    “…Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Early diagnosis improves the prognosis. Protein induced by vitamin K…”
    Get full text
    Journal Article Book Review
  3. 3

    MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1 by Yuan, Jianyong, Ji, Hongxiang, Xiao, Feng, Lin, Zhipeng, Zhao, Xijun, Wang, Zhouchong, Zhao, Jun, Lu, Junhua

    “…Increasing evidence indicates that dysregulation of microRNAs (miRNAs) contributes to tumorigenesis. MicroRNA-340 (miR-340) is downregulated in several types…”
    Get full text
    Journal Article
  4. 4

    Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt/β-catenin signaling by Wei, Yongpeng, Shen, Ningjia, Wang, Zhouchong, Yang, Guangshun, Yi, Bin, Yang, Ning, Qiu, Yinghe, Lu, Junhua

    Published in Molecular and cellular biochemistry (01-09-2013)
    “…Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Systemic chemotherapy plays an important role in the treatment of patients with…”
    Get full text
    Journal Article
  5. 5

    First-in-human (FIH) phase I study of GST-HG161, a potent and highly selective c-met inhibitor, in patients with advanced solid tumor by Li, Jin, Guo, Ye, Xue, Junli, Wu, Wenqiang, Chen, Shikui, Tang, Yanan, Xu, Xiongbin, Li, Gang, Hu, Lihong, Lin, Yunfei, Shen, Liang, Xia, Yuanfeng, Chan, Chi-Chung, Wang, Zhouchong, Ni, Dawen, Ding, Charles, Chen, Shuhui

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e16126 Background: GST-HG161 is an orally bioavailable novel potent and highly selective c-Met inhibitor, which displayed significant antitumor…”
    Get full text
    Journal Article
  6. 6

    Surgery for hepatocellular carcinoma presenting with variceal bleeding: The eastern experience by Yang, Tian, He, Haiguan, Yuan, Jianyong, Zhang, Jin, Lu, Junhua, Lau, Wan Yee, Yang, Guangshun, Shen, Yinan, Wang, Zhouchong, Alshebeeb, Kutaiba, Wu, Mengchao, Shen, Feng

    Published in Journal of surgical oncology (01-02-2016)
    “…Background Variceal bleeding can be the first manifestation of patients with newly diagnosed hepatocellular carcinoma (HCC), and effective treatments deserve…”
    Get full text
    Journal Article
  7. 7

    Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt/[beta]-catenin signaling by Wei, Yongpeng, Shen, Ningjia, Wang, Zhouchong, Yang, Guangshun, Yi, Bin, Yang, Ning, Qiu, Yinghe, Lu, Junhua

    Published in Molecular and cellular biochemistry (01-09-2013)
    “…Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Systemic chemotherapy plays an important role in the treatment of patients with…”
    Get full text
    Journal Article